[Adapted physical activity and metastatic cancer: What needs and expectations?]

Activité Physique Adaptée et cancer métastatique : quels besoins et quelles attentes ?
Activité physique adaptée Adapted physical activity Cancer métastatique Metastatic cancer Oncologist Oncologue Patient Prescription

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 07 03 2022
revised: 04 07 2022
accepted: 25 07 2022
pubmed: 24 10 2022
medline: 30 11 2022
entrez: 23 10 2022
Statut: ppublish

Résumé

This French study aimed to evaluate oncologists' and patients' perception of physical activity, particularly adapted physical activity, in order to identify the obstacles and levers to its practice in patients with metastatic cancer. Between October 2019 and March 2020, 60 medical oncologists and 305 patients with metastatic cancer were asked to fill in a self-completed questionnaire. The benefits of physical activity are recognised by most oncologists and patients. These benefits were perceived more by oncologists in prevention (78%) or in the early stage (72%) of the disease than in the metastatic stage (55%) (P=0.01). Patient's physical condition (45%) and age (37%) but also the lack of time during the consultation to explain supportive care (35%) are the main obstacles identified by the oncologist to the integration of physical activity into patient care. Furthermore, lack of knowledge of adapted programmes is the main reason given by the physicians who have never prescribed physical activity (51%). On the patient side, while 88% of them had heard of the benefits of physical activity, only 11% had received a prescription. Most oncologists and patients were very interested in receiving information on where and what types of activities to practice, as well as what to avoid. Efforts in terms of information for both oncologists and patients seem necessary to increase the level of physical activity prescription and practice for patients followed for metastatic cancer.

Identifiants

pubmed: 36273935
pii: S0007-4551(22)00312-5
doi: 10.1016/j.bulcan.2022.07.011
pii:
doi:

Types de publication

English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

1287-1297

Informations de copyright

Copyright © 2022 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Thierry Bouillet (T)

AP-HP, Hôpital Avicenne, département d'oncologie médicale, Bobigny, France; Association CAMI Sport & Cancer, Paris, France. Electronic address: tbouillet@aol.com.

Florence Joly (F)

Hôpital François-Baclesse, département d'oncologie médicale, Unicaen Normandie, Caen, France.

Mahasti Saghatchian (M)

Hôpital Américain de Paris, département d'oncologie médicale, Neuilly-sur-Seine, France; Université de Paris, Paris, France.

Laure Guéroult-Accolas (L)

Association Patients en réseau, Paris, France.

Jean-Marc Tahar (JM)

Association pour la Recherche sur les Tumeurs du Rein (A.R.Tu.R.), Paris, France.

Jean-Marc Descotes (JM)

Association CAMI Sport & Cancer, Paris, France.

Ivan Krakowski (I)

Association Francophone pour les Soins Oncologiques de Support (AFSOS), Talence, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH